Currently Viewing
CLL Survivors Worried About Life Expectancy, Quality of Life
December 25, 2017 – Brielle Urciuoli
How to Be Proactive and Prevent Malnutrition
December 24, 2017 – Kristie L. Kahl
Four-Drug Combination Improves NSCLC Outcomes
December 24, 2017 – Silas Inman
Childhood Cancer Survivors at Increased Risk for High Blood Pressure
December 23, 2017 – Kristie L. Kahl
FDA Approves New Breast Cancer Radiotherapy
December 22, 2017 – Silas Inman
ROS1 Testing Is Increasingly Important in Lung Cancer
December 22, 2017 – CURE Staff
Immunotherapy Is Entering the Stage 3 Lung Cancer Landscape
December 22, 2017 – Danielle Bucco
Tafinlar Plus Mekinist Combination Granted Priority Review for Melanoma Treatment
December 22, 2017 – Jason M. Broderick
Expert Looks Ahead to Promising Liver Cancer Advancements
December 21, 2017 – Gina Columbus

CLL Survivors Worried About Life Expectancy, Quality of Life

While patients with chronic lymphocytic leukemia (CLL) tend to have long life expectancies, with many prescribed to a “watch-and-wait” approach, a recent study by the Cancer Support Community (CSC) found that more than half of patients living with the disease reported that having CLL affects their viewpoints regarding their life expectancy.
 
BY Brielle Urciuoli
PUBLISHED December 25, 2017
While patients with chronic lymphocytic leukemia (CLL) tend to have long life expectancies, with many prescribed to a “watch-and-wait” approach, a recent study by the Cancer Support Community (CSC) found that more than half of patients living with the disease reported that having CLL affects their viewpoints regarding their life expectancy.

“This study is an important first step into understanding the challenges and concerns specific to CLL patients and the psychosocial consequences of being diagnosed with CLL,” said Linda House, CSC president, in a release.

The CSC is the world’s largest professionally led network of cancer supports, and presented their findings at the 2017 American Society of Hematology (ASH) Annual Meeting and Exposition.

The study involved 134 people with CLL who were enrolled in the CSC’s online Cancer Experience Registry. Participants completed surveys that examined both health-related quality of life and financial issues.

In the group, 49 patients (37 percent) were undergoing a watch-and-wait approach; eight patients (6 percent) were undergoing their first line of treatment; 16 (12 percent) their active second or subsequent treatment; and 52 (39 percent) were in remission.

Despite the fact that only five patients (4 percent) were reported to be in poor health (the others being excellent, very good, good and fair), 62 percent said that CLL “somewhat to very much” affected their views on life expectancy.

Forty-one percent reported concerns about their quality of life, 40 percent were worried about finances and 34 percent had concerns regarding their ability to work. About a quarter of patients (26 percent) also worried about relationships with their family and friends.

Overall, patients involved in the study reported a substantially worse quality of life – especially when it came to anxiety and fatigue – compared to the general population in the United States, however, it is unclear how disease advancement and treatment contribute to poor quality of life.

“These findings highlight the importance of examining changes in quality of life and distress throughout the cancer experience and that psychosocial services, like those offered through CSC, play a vital role in supporting patients and survivors who have these symptoms and concerns,” said Alexandra Zaleta, Ph.D., CSC Senior Director of Research.

Looking forward, the researchers outlined that further research is needed regarding the factors that put patients with CLL at greater risk for poor outcomes, as well as the interventions currently in place to address emotional distress and quality of life, particularly with those who are progressing on the disease.

 
Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the CLL CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In